Drug details
Elevidys (delandistrogene moxeparvovec-rokl suspension)
type of Neurologics, Other
Elevidys (delandistrogene moxeparvovec-rokl) is an adeno-associated virus vector-based gene therapy indicated for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene.
This drug may have the following side effects:
- nausea,
- vomiting,
- fever, and
- increased values on liver function test,
- low blood platelets (thrombocytopenia).